Related Experiment Videos

Intravitreal effects of pimaricin in experimental fungal endophthalmitis

Insights

Pimaricin at 25 micrograms intravitreally was ineffective against Aspergillus endophthalmitis in rabbits. Higher doses caused retinal damage, but a spaced dosage regimen may prove effective.

Area of Science:

  • Ophthalmology
  • Mycology
  • Pharmacology

Background:

  • Fungal endophthalmitis, particularly Aspergillus, poses a significant threat to vision.
  • Intravitreal antifungal agents are crucial for treating endogenous fungal endophthalmitis.
  • Pimaricin is a potential antifungal agent, but its efficacy and safety in ocular infections require investigation.

Purpose of the Study:

  • To evaluate the efficacy and safety of different intravitreal doses of pimaricin in a rabbit model of Aspergillus endophthalmitis.
  • To determine the optimal dosage and administration regimen for pimaricin to treat fungal endophthalmitis while minimizing ocular toxicity.

Main Methods:

  • Albino rabbits were induced with Aspergillus endophthalmitis.
  • Intravitreal injections of pimaricin at doses of 25, 50, and 100 micrograms were administered.
  • Ocular toxicity, retinal function, and fungal inhibition were assessed.

Main Results:

  • 25 mug of pimaricin was nontoxic but ineffective against fungal growth.
  • 50 mug of pimaricin demonstrated antifungal efficacy but caused significant retinal damage, including functional loss and iridoplegia.
  • Doses exceeding 50 mug led to severe complications like vitreous retraction, degeneration, iridoplegia, and retinal detachment.

Conclusions:

  • Single high-dose intravitreal pimaricin is associated with significant ocular toxicity.
  • A lower dose of 25 micrograms of pimaricin, administered in a fractionated regimen (three doses, three days apart), may offer a safer and potentially effective treatment for fungal endophthalmitis.
  • Further studies are warranted to confirm the efficacy and safety of fractionated pimaricin dosing.

Related Concept Videos